SHC calls off RTO, faces delisting if new business not found
DeeperDive is a beta AI feature. Refer to full articles for the facts.
SHC Capital faces potential delisting again after calling off a reverse takeover deal with Chinese equipment maker Tong Da Medical Device.
SHC, a cash company that was previously involved in underwriting insurance risks, said it could not make significant progress with Tong Da and its owners in carrying out a financial audit and other due diligence of the Chinese company.
Both parties agreed to terminate the deal as of Oct 31, SHC said. The company has spent about S$1.4 million so far on the terminated deal.
SHC has until Jan 31, 2016 to find a new business, or it will be delisted from the Catalist board.
The company said it is exploring options, including a voluntary liquidation if SHC cannot obtain a further extension of time to find a new business. If there is a voluntary liquidation, the company may make a distribution via a capital reduction or an interim distribution.
The company reported on Monday that it had S$38.9 million of net assets as at Oct 31, including S$39.3 million of cash and bank balances.
Navigate Asia in
a new global order
Get the insights delivered to your inbox.
SHC shares were not traded on Monday, but were bid at 12.9 Singapore cents and offered at 13.3 Singapore cents.
Copyright SPH Media. All rights reserved.
TRENDING NOW
Shelving S$5 billion office redevelopment plan proved ‘wise’ as geopolitical risks mount: OCBC chairman
China pips the US if Asean is forced to choose, but analysts warn against reading it like a sports result
Beijing’s calculated silence on the Iran war
Middle East-linked energy supply shocks put Asean Power Grid back in focus